Related Experiment Videos

[Xeroderma pigmentosum. A study in 40 Algerian patients]

B Bouadjar1, F Aït-Belkacem, L Daya-Grosjean

  • 1Clinique de Dermatologie, CHU Mustapha, Alger.

Annales De Dermatologie Et De Venereologie
|January 1, 1996
PubMed
Summary

Xeroderma pigmentosum (XP) in Algeria presents primarily as classic XP with high rates of ocular and neurological issues. Genetic analysis reveals Ha-ras gene alterations and p53 mutations, with surgery as the primary treatment for tumors.

Related Concept Videos